From: Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy
Target gene | Effect | Function | Ref. |
---|---|---|---|
HO-1 | Repression | Maintenance of heme homeostasis and regulation of oxidative stress | [4] |
YAP | Promotion | Facilitates the expression of YAP by binding to its promotor, in turn promoting the transcription of ICAM1 and VCAM1 | [8] |
PGC-1α | Repression | Reduces the production of ROS and improves angiogenesis after hindlimb ischemia | [51] |
ANGPT-1 | Repression | Inhibits angiogenesis | |
FGF-2 | |||
VEGF | |||
IL-8 | |||
Perp | Repression | Represses p53-induced cellular senescence | [35] |
P21 | |||
ITPR2 | Repression | Decreases calcium efflux from the endoplasmic reticulum | [6] |
CALM1 | Repression | Activated when combined with calcium and represses the cell cycle | [6] |
EWSR1 | Repression | Mediates the transcriptional percent of cell cycle proteins D1a and D1b | [110] |
Cebpb | Repression | Inhibits myeloid differentiation | [56] |
Ebf1 | Promotion | Promotes the differentiation of pro-B cells | [56] |
Spic | Repression | Inhibits monocyte differentiation into red marrow and bone marrow macrophages | [59] |
FIZZ1 | Repression | Inhibits the differentiation of M2 macrophages | [61] |
CD206 | |||
YM1 | |||
iNOS | Promotion | BACH1 deficiency in macrophages promotes NLRP3 inflammasome activation | [62] |
COX-2 | Repression | ||
HK2 | Promotion | Supports aerobic glycolysis | [9] |
GAPDH | |||
SLC16A | Repression | Reduces lactate utilization in TNBC cells to repress tumorigenesis | [73] |
LDHB | |||
FOXA1 | Repression | Promotes EMT-mediated tumor metastasis by inhibiting epithelial genes | |
CLDN3 | |||
CLDN4 | |||
VIM | Promotion | Promotes EMT-mediated metastasis by inhibiting mesenchymal genes | |
CDH2 | |||
SNAI2 | |||
IGF1R | Promotion | Promotes tumor growth and metastasis by upregulating the expression of cell motility-related genes | [12] |
PTK2 | |||
COL1A1 | Promotion | Facilitates ECM remodeling to create an environment favorable to tumor metastasis | |
Fibronectin | |||
TGFBR2 | Promotion | Activates the smad2/3 signaling pathway thereby promoting ECM remodeling | [87] |
MMP1 | Promotion | Promotes metastasis | |
CXCR4 | |||
OPN | |||
FHL1 | |||
MMP9 | Promotion | Promotes angiogenesis and tumor metastasis | |
CEMIP | Promotion | Promotes metastasis | [30] |
CD44+ | Promotion | Induces stemness, proliferation and invasion of lung CSCs both in vitro and in vivo | [106] |
SOX2 | Promotion | Maintains CSC identity and promotes self-renewal | [106] |
NANOG | |||
OCT4 | |||
PDLIM2 | Repression | ROS/BACH1/PDLIM2/STAT3 signaling pathway promotes lung tumorigenesis by driving alveolar macrophages | [139] |
GCLC | Repression | Reduces oxidation and promotes ferroptosis | |
GCLM | |||
SLC7A11 | |||
HIF1A | Repression | Inhibits the proliferation of PDAC | [109] |
VEGF | |||
PTEN | Promotion | ||
FTH1 | Repression | Affects iron homeostasis and promotes ferroptosis via the ferritin-ferroportin pathway | |
FTL | |||
SLC40A1 | |||
CDH1 | Repression | Promotes ferroptosis by suppressing the NF2-Hippo pathway and facilitates metastasis by promoting the EMT | [126] |
VEGFC | Promotion | Promotes angiogenesis and tumor progression | |
MGMT | Promotion | Competitively binds to p53 and reduces its impact on MGMT expression | [134] |